Research Summary
Analyzed using Evidence Intelligence™

Web-Based Diabetes Management Improves Glycemic Control

Last updated August 29, 2026

Key finding

HbA1c level decreased from 8.6% at baseline to 7.4% at 24 weeks (P <.001).

This pilot study evaluated a web-based diabetes management platform with algorithm-driven insulin adjustments in patients with Type 2 Diabetes, showing significant improvements in HbA1c and fasting plasma glucose.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This pilot study evaluated a web-based diabetes management platform with algorithm-driven insulin adjustments in patients with Type 2 Diabetes, showing significant improvements in HbA1c and fasting plasma glucose.

Clinical relevance

This study highlights the potential of digital health solutions in managing Type 2 Diabetes, particularly in improving glycemic control. With the increasing prevalence of diabetes, effective management strategies are crucial for reducing complications and improving patient outcomes. The findings suggest that technology-driven interventions can enhance patient engagement and adherence to treatment protocols.

Keep in mind

Single-arm study limits generalizability High incidence of hypoglycemia may raise safety concerns Short follow-up duration may not capture long-term effects

Published in

Journal Reference

Publication details and source links for this paper.

Nishanth T, Hong CT, Suresh RC, et al. Efficacy and Safety of a Web-Based Diabetes Management Platform with Algorithm-Driven Insulin Dose Adjustments in Patients with Type 2 Diabetes: A Pilot Study. JMIR Formative Research. 2025;9:e68914. doi:10.2196/68914

Main Effects

HbA1c decreased from 8.6% to 7.4% (P <.001)

Fasting plasma glucose decreased from 8.7 mmol/L to 7.1 mmol/L (P <.001)

Total daily insulin dose increased from 0.73 to 0.79 units/kg/day (P =.007)

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to ALRT telehealth solution and Adherence to self-monitoring of blood glucose (SMBG), BMI, Fasting Plasma Glucose (FPG), and 3 more.

Primary intervention

ALRT telehealth solution

Primary outcomes

  • Adherence to self-monitoring of blood glucose (SMBG)
  • BMI
  • Fasting Plasma Glucose (FPG)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

6
Evidence pairs
6
Relationships
4
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 72

4

Related topics

6

Evidence pairs

1865

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 6 evidence relationships
  • Includes primary outcome data
  • Linked to 4 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

Fasting Blood Glucose

matched_outcome

Related evidence

Evidence topic

Glycemic Control

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Adherence to self-monitoring of blood glucose (SMBG)

ALRT telehealth solution → Adherence to self-monitoring of blood glucose (SMBG)

ALRT telehealth solution → Adherence to self-monitoring of blood glucose (SMBG)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

BMI

ALRT telehealth solution → BMI

ALRT telehealth solution → BMI

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
25
Negative
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Fasting Plasma Glucose (FPG)

ALRT telehealth solution → Fasting Plasma Glucose (FPG)

ALRT telehealth solution → Fasting Plasma Glucose (FPG)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

HbA1c

ALRT telehealth solution → HbA1c

ALRT telehealth solution → HbA1c

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Incidence of hypoglycemia

ALRT telehealth solution → Incidence of hypoglycemia

ALRT telehealth solution → Incidence of hypoglycemia

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Total daily insulin dose

ALRT telehealth solution → Total daily insulin dose

ALRT telehealth solution → Total daily insulin dose

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
25
Negative
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • HbA1c levels improved significantly by 1.2% (P <.001)
  • Fasting plasma glucose levels decreased by 1.6 mmol/L (P <.001)
  • 97.3% adherence to SMBG measurements was reported
who this applies

Who this applies to

  • Adults with Type 2 Diabetes
  • Patients requiring insulin therapy
  • Individuals interested in digital health solutions
keep in mind

Keep in Mind

  • Results may not be applicable to all diabetes populations
  • Potential for selection bias in participant recruitment
  • Further studies needed to evaluate long-term outcomes
between the lines

Between the Lines

  • Single-arm study limits generalizability
  • High incidence of hypoglycemia may raise safety concerns
  • Short follow-up duration may not capture long-term effects

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on ALRT telehealth solution and Body Mass Index, ALRT telehealth solution and Insulin Resistance.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does ALRT telehealth solution improve adherence to self-monitoring of blood glucose (SMBG)?

Emerging Evidence

ALRT telehealth solution appears to improve adherence to self-monitoring of blood glucose (SMBG).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Adherence to self-monitoring of blood glucose (SMBG)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does ALRT telehealth solution improve fasting plasma glucose (FPG)?

Emerging Evidence

ALRT telehealth solution appears to improve fasting plasma glucose (FPG).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Fasting Plasma Glucose (FPG)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does ALRT telehealth solution lower HbA1c?

Emerging Evidence

ALRT telehealth solution appears to lower HbA1c.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does ALRT telehealth solution reduce incidence of hypoglycemia?

Emerging Evidence

Current evidence does not show a clear reduction in incidence of hypoglycemia with ALRT telehealth solution.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Incidence of hypoglycemia

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.